-
Federal Register › Food and Drug Administration
10609 results for Federal Register › Food and Drug Administration
-
vLex Rating
- Drug Development Tool Process Under the 21st Century Cures Act and Prescription Drug User Fee Act VI; Public Meeting; Request for Comments
- Determination of Regulatory Review Period for Purposes of Patent Extension; TALTZ
- Cigarettes, Smokeless Tobacco, and Covered Tobacco Products; Change of Office Name and Address; Technical Amendment
- Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
- Tobacco Products Scientific Advisory Committee; Notice of Meeting
- Generic Drug User Fee Amendments II Program Fee: List of Abbreviated New Drug Application Sponsors and Application Numbers; Request for Information and Comments
- Battery Safety Concerns in Electronic Nicotine Delivery Systems; Public Workshop; Establishment of a Public Docket; Request for Comments
- Food Labeling; Nutrition Labeling of Standard Menu Items in Restaurants and Similar Retail Food Establishments; Extension of Compliance Date
- Novus International, Inc.; Filing of Food Additive Petition (Animal Use); Reopening of the Comment Period
- Medical Devices; Neurological Devices; Classification of the Neurovascular Mechanical Thrombectomy Device for Acute Ischemic Stroke Treatment
- International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Bioequivalence: Blood Level Bioequivalence Study; Guidance for Industry; Availability
- Determination That SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER (Sodium Chloride), Injectable, 234 Milligrams/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
- Agency Information Collection Activities; Proposed Collection; Comment Request; Recommended Glossary and Educational Outreach To Support Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use
- Determination of Regulatory Review Period for Purposes of Patent Extension; ZILVER PTX DRUG ELUTING PERIPHERAL STENT
- Product-Specific Bioequivalence Recommendations; Draft and Revised Draft Guidances for Industry; Availability
- Factors To Consider Regarding Benefit-Risk in Medical Device Product Availability, Compliance, and Enforcement Decisions; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
- Agency Information Collection Activities; Proposals, Submissions, and Approvals:
- Meetings:
- Revised Guidance for Industry; Availability:
- Agency Information Collection Activities; Proposals, Submissions, and Approvals:
- Requests for Nominations, etc.:
- Requests for Nominations, etc.:
- Meetings:
- Meetings:
- Agency Information Collection Activities; Proposals, Submissions, and Approvals:
- Small Entity Compliance Guides; Availability:
- Food Safety Modernization Act:
- Bar Code Technologies for Drugs and Biological Products:
- Guidance for Industry; Availability:
- Small Entity Compliance Guide; Availability:
Free signup to view additional results